906 Systemic HMGB1 Administration Ameliorates Cutaneous and Non-Cutaneous Manifestations in a Dystrophic Epidermolysis Bullosa Model Mouse

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2017.02.933
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

1039 Novel Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Recessive Dystrophic Epidermolysis Bullosa Inversa

2020English

Dilated Cardiomyopathy in Dystrophic Epidermolysis Bullosa

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2000English

935 Clinical Manifestations and Quality of Life in Patients With Recessive Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Cutaneous Manifestations of Systemic Lupus Erythematosus

International Journal of Research in Dermatology
2018English

The Cutaneous Manifestations of Systemic Diseases

JAMA - Journal of the American Medical Association
Medicine
1954English

Anesthetic Management of a Patient With Dystrophic Epidermolysis Bullosa.

THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
1998English

Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa

New England Journal of Medicine
Medicine
2010English

Image Gallery: Multiple Localized Lipoatrophy in Recessive Dystrophic Epidermolysis Bullosa

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy